Prevalence and prediction of trismus in patients with head and neck cancer: A cross-sectional study.

Sarah J van der GeerPhillip V van RijnJolanda I KamstraJohannes A LangendijkBernard F A M van der LaanJan L N RoodenburgPieter U Dijkstra

Published in: Head & neck (2018)

About one-fourth of patients with head and neck cancer develop trismus. Based on prevalence and associated factors of trismus, a simple calculation tool predicts the risk of trismus in these patients.

Keyphrases

risk factors
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
physical activity
patient reported outcomes